Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

He & She MD vs Omzo

He & She MD
Graded #92

Higher grade

vs+17.299999999999997
Omzo
Graded #459

Lower grade

The verdict

He & She MD takes it — 71.5/100 to 54.2/100.

He & She MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. He & She MD is a nationwide telehealth weight-loss clinic offering doctor-prescribed GLP-1 medications: compounded semaglutide and tirzepatide (injectable or oral) plus a microdose option, with brand-name…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHe & She MD +9
54
45
Dose & formulationHe & She MD +48
88
40
Clinical oversightHe & She MD +8
84
76
Labs & monitoringHe & She MD +10
62
52
FulfillmentHe & She MD +29
92
63
Contract termsOmzo +14
41
55
He & She MD · left barOmzo · right bar

The numbers

MetricHe & She MDOmzo
WeighScore71.5/10054.2/100
GradeCC
Scorecard rank#92#459
Semaglutide$139/mo (starting dose, promotional rate, compounded)Not disclosed
Tirzepatide$199/mo (starting dose, compounded)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
He & She MD

Graded #92 · C

Strengths

  • Transparent intro pricing: injectable GLP-1 from $139/month, oral from $199, microdose from $99
  • Compounded semaglutide and tirzepatide (injectable or oral) plus brand access to Ozempic, Wegovy, Zepbound
  • Only charged if medication is prescribed; no hidden fees
  • Free expedited shipping and unlimited board-certified clinician access
  • GLP-1 coaching, nutrition guidance, and in-app progress tracking

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products (per the site FDA disclaimer)
  • Does not ship to Louisiana or to PO boxes
  • Introductory pricing rises after the 6-month (or 3-month microdose) plan
  • Cash-pay model — insurance billing not indicated
Omzo

Graded #459 · C

Strengths

  • Compounded GLP-1 (semaglutide and tirzepatide) with clinician guidance
  • Free, discreet delivery on all treatments
  • FSA/HSA eligible
  • Multi-pillar: also women's hormone, sexual health, hair, skin, and daily health

Where it loses points

  • Pricing not published on the site — shown only after the intake quiz
  • Compounding pharmacy partner not named (states only 'independent state-licensed')
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)
  • Legal entity not named; governing law given only as 'the state in which Omzo operates'

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard